QSAR models for reproductive toxicity and endocrine disruption activity

Marjana Novic1, Marjan Vracko

  • 1National Institute of Chemistry, Hajdrihova 19, 1000 Ljubljana, Slovenia. marjana.novic@ki.si

Insights

Developing alternative in vitro and in silico methods can reduce the cost and animal use associated with reproductive toxicity testing for chemical registration. This review explores various modeling approaches for predicting chemical reproductive toxicity.

Area of Science:

  • Toxicology
  • Computational Chemistry
  • Regulatory Science

Background:

  • Reproductive toxicity is a critical regulatory endpoint for chemical registration, including pesticides.
  • Current in vivo testing methods are costly, time-consuming, and necessitate animal sacrifice.
  • There is a significant need for validated alternative methods to assess reproductive toxicity.

Purpose of the Study:

  • To review and present various computational modeling approaches for evaluating reproductive toxicity.
  • To highlight the potential of in vitro and in silico methods as alternatives to traditional in vivo testing.

Main Methods:

  • Description of the CAESAR model for predicting reproductive toxicity.
  • Development of a classification model for endocrine disruption potential using artificial neural networks.
  • Modeling of relative binding affinity to the rat estrogen receptor.
  • Receptor-dependent modeling experiments.

Main Results:

  • The review outlines diverse modeling strategies applicable to reproductive toxicity assessment.
  • Specific examples demonstrate the utility of QSAR, neural networks, and receptor binding models.
  • These computational approaches offer promising alternatives for regulatory evaluations.

Conclusions:

  • In silico and in vitro methods show significant promise for replacing or reducing animal testing in reproductive toxicity assessments.
  • Modeling approaches provide efficient and cost-effective tools for regulatory submissions.
  • Further development and validation of these alternative methods are crucial for their widespread adoption.

Related Concept Videos

Structure-Activity Relationships and Drug Design01:28

Structure-Activity Relationships and Drug Design

Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence its...
Toxicity Testing in Animals01:23

Toxicity Testing in Animals

Toxicity tests in animals are grounded on two main assumptions: first, the effects observed in laboratory animals can be extrapolated to humans, especially when adjusted for body surface area; second, high-dose exposure in animals is essential to identify potential human hazards from lower doses. This is based on the quantal dose-response concept, which faces the challenge of extrapolating results from relatively few test animals to much larger human populations. For example, a 0.01% incidence...
Mutagenicity and Carcinogenicity01:25

Mutagenicity and Carcinogenicity

Mutagenicity and carcinogenicity refer to the ability of drugs to cause genetic defects and induce cancer, respectively. The International Agency for Research on Cancer (IARC) classifies agents into four groups based on their carcinogenic potential. Group 1 agents are known human carcinogens; group 2A agents are probably carcinogenic to humans; group 3 agents lack data to support their role in carcinogenesis; and group 4 includes agents for which data support that they are not likely to be...
Pharmacodynamic Models: Overview01:27

Pharmacodynamic Models: Overview

Pharmacodynamic (PD) responses describe the interaction between a drug and its biological target, culminating in a physiological effect. These responses can be classified into different types: continuous variables, such as blood glucose levels; categorical outcomes, like survival rates; and time-to-event metrics, such as disease progression. Understanding and modeling PD responses are critical for optimizing drug efficacy and safety.PD models describe the relationship between drug concentration...